Minerva Neurosciences, Inc.
NERV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $13,019 | $12,867 | $16,803 |
| - Cash | $12,287 | $15,248 | $17,290 | $21,362 |
| + Debt | $0 | $60,000 | $60,000 | $60,000 |
| Enterprise Value | – | $57,771 | $55,577 | $55,441 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,743 | -$3,257 | -$3,752 | -$4,271 |
| % Margin | – | – | – | – |
| Net Income | -$2,744 | -$3,259 | -$3,753 | -$4,272 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.36 | -0.43 | -0.5 | -0.56 |
| % Growth | 16.3% | 14% | 10.7% | – |
| Operating Cash Flow | -$2,916 | -$2,042 | – | -$5,167 |
| Capital Expenditures | -$0 | -$0 | – | $0 |
| Free Cash Flow | -$2,916 | -$2,042 | – | -$5,167 |